By vgreene, 5 June, 2019 The Drug Interactions section of Epocrates drug monographs includes clinically relevant identified and evidence-based theoretical interactions that are both pharmacokinetic and pharmacodynamic in nature. Epocrates’ medical information editors go far beyon
By vgreene, 5 June, 2019 Epocrates drug monographs include the contraindication “hypersens. to drug/class/compon.,” a phrase meant to globally convey that hypersensitivity to the drug, drug class, or the inactive ingredients is a contraindication for use. Epocrates drug monograph
By vgreene, 5 June, 2019 The Manufacturer/Pricing section of each Epocrates drug monograph identifies the legal status of the product (e.g., OTC, Rx, or controlled substance) and gives the DEA schedule, when relevant.
By vgreene, 5 June, 2019 The Black Box Warnings section of Epocrates drug monographs includes content adapted from boxed warnings appearing in the US prescribing information. Epocrates may add content to this section before it’s published in the US prescribing information if the
By vgreene, 5 June, 2019 The Alternatives section of an Epocrates OTC monograph includes various links to similar products to allow for easy and fast alternative product selection. First are listed other OTC products with the same active ingredients, but which may be available in